SCHEMBL29270794

SCHEMBL29270794

CC(C)(C[C@H]1CSc2ccc(C(=O)NNC(=O)C(C)(C)C)cc2NC1=O)NC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 2/20 0.39
▸ HDAC8 Q9BY41 2/20 0.39
▸ HDAC6 Q9UBN7 2/20 0.39
▸ POLB P06746 3/20 0.38
▸ HPGD P15428 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ RAB9A P51151 5/20 0.36
▸ NPC1 O15118 4/20 0.36
▸ HTT P42858 2/20 0.35
▸ LMNA P02545 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MAPT P10636 2/20 0.34
▸ ATM Q13315 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ PABPC1 P11940 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29270742 0.89 HDAC1 (0.41) HDAC1HDAC8HDAC6POLBHPGD
SCHEMBL26961985 0.82 HDAC1 (0.42) HDAC1HDAC8HDAC6POLBHPGD
SCHEMBL29270724 0.80 SSTR4 (0.36) HDAC1HDAC8HDAC6POLBSMN1; SMN2
SCHEMBL29270801 0.78 LMNA (0.35) HDAC1HDAC8HDAC6POLBSMN1; SMN2
SCHEMBL31628254 0.76 HDAC1 (0.40) HDAC1HDAC8HDAC6POLBHPGD
SCHEMBL31628244 0.76 NAAA (0.40) HDAC1HDAC8HDAC6POLBHPGD
SCHEMBL31375556 0.76 NAAA (0.40) HDAC1HDAC8HDAC6POLBHPGD
SCHEMBL26962726 0.75 HDAC1 (0.39) HDAC1HDAC8HDAC6POLBHPGD
SCHEMBL29796820 0.75 HDAC1 (0.39) HDAC1HDAC8HDAC6POLBHPGD
SCHEMBL29270708 0.75 TP53 (0.34) HDAC1HDAC8HDAC6POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116964048-A Bicyclic tetrahydroazepine derivatives for the treatment of cancer 豪夫迈·罗氏有限公司 2023-10-27 — — CN disclosed
Send feedback